Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Nov 13, 2023 · 10-Q · 44 days after period end · 0001640334-23-002073
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$2.45M | -$2.33M | -$2.25M | -$344.88K |
| EPS Diluted | -$0.83 | — | — | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 13, 2023 · 44 d after period end
